establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.
Company profile
Ticker
ESTA
Exchange
Website
CEO
Juan Jose Chacon Quiros
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
SEC CIK
Corporate docs
Subsidiaries
Establishment Labs, S.A. • Motiva USA, LLC • JAMM Technologies, Inc. • Establishment Labs Produtos par Saude Ltda • European Distribution Center Motiva BV • Motiva Implants France SAS • JEN-Vault AG • Motiva Nordica AB • Motiva Implants UK Limited • Motiva Implants Spain, S.L. ...
ESTA stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
5 Mar 24
10-K
2023 FY
Annual report
4 Mar 24
NT 10-K
Notice of late annual filing
1 Mar 24
8-K
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
28 Feb 24
8-K
Entry into a Material Definitive Agreement
22 Feb 24
8-K
Other Events
31 Jan 24
424B7
Prospectus with selling stockholder info
31 Jan 24
D
$50.00 mm in equity / options / securities to be acquired, sold $50.00 mm, 10 investors
24 Jan 24
8-K
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
9 Jan 24
8-K
Departure of Directors or Certain Officers
14 Dec 23
Transcripts
ESTA
Earnings call transcript
2023 Q4
28 Feb 24
ESTA
Earnings call transcript
2023 Q3
7 Nov 23
ESTA
Earnings call transcript
2023 Q2
8 Aug 23
ESTA
Earnings call transcript
2023 Q1
8 May 23
ESTA
Earnings call transcript
2022 Q4
27 Feb 23
ESTA
Earnings call transcript
2022 Q3
8 Nov 22
ESTA
Earnings call transcript
2022 Q2
9 Aug 22
ESTA
Earnings call transcript
2022 Q1
10 May 22
ESTA
Earnings call transcript
2021 Q4
1 Mar 22
ESTA
Earnings call transcript
2021 Q3
9 Nov 21
Latest ownership filings
4
Samuel Ross Mansbach
19 Mar 24
4
Raj Denhoy
19 Mar 24
4
Quiros Juan Jose Chacon
19 Mar 24
4
Samuel Ross Mansbach
7 Mar 24
4
Raj Denhoy
7 Mar 24
4
EDWARD J SCHUTTER
5 Mar 24
4
Bryan Slotkin
5 Mar 24
SC 13G/A
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G
Chacon Quiros Juan Jose
9 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 52.19 mm | 52.19 mm | 52.19 mm | 52.19 mm | 52.19 mm | 52.19 mm |
Cash burn (monthly) | 12.66 mm | 1.10 mm | 9.53 mm | 5.72 mm | 10.50 mm | 7.87 mm |
Cash used (since last report) | 75.81 mm | 6.56 mm | 57.08 mm | 34.27 mm | 62.88 mm | 47.08 mm |
Cash remaining | -23.62 mm | 45.63 mm | -4.89 mm | 17.92 mm | -10.69 mm | 5.11 mm |
Runway (months of cash) | -1.9 | 41.6 | -0.5 | 3.1 | -1.0 | 0.6 |
Institutional ownership, Q3 2023
76.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 105 |
Opened positions | 12 |
Closed positions | 17 |
Increased positions | 39 |
Reduced positions | 29 |
13F shares | Current |
---|---|
Total value | 1.01 tn |
Total shares | 20.75 mm |
Total puts | 41.10 k |
Total calls | 968.70 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
JW Asset Management | 3.19 mm | $156.66 bn |
RTW Investments | 2.49 mm | $122.39 bn |
Nantahala Capital Management | 1.89 mm | $92.63 bn |
Brown Advisory | 1.48 mm | $72.73 bn |
Cowen And | 1.14 mm | $56.00 bn |
JPM JPMorgan Chase & Co. | 872.61 k | $42.82 bn |
Citadel Advisors | 624.28 k | $30.63 bn |
Nicholas Investment Partners | 620.62 k | $30.45 bn |
Magnetar Financial | 606.02 k | $29.74 bn |
Iron Triangle Partners | 570.13 k | $27.98 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Mar 24 | Samuel Ross Mansbach | Common Shares | Grant | Acquire A | No | No | 0 | 5,406 | 0.00 | 10,812 |
6 Mar 24 | Samuel Ross Mansbach | Stock Option Common Shares | Grant | Acquire A | No | No | 49.25 | 7,691 | 378.78 k | 7,691 |
6 Mar 24 | Raj Denhoy | Common Shares | Grant | Acquire A | No | No | 0 | 5,644 | 0.00 | 13,447 |
6 Mar 24 | Raj Denhoy | Stock Option Common Shares | Grant | Acquire A | No | No | 49.25 | 8,030 | 395.48 k | 8,030 |
6 Mar 24 | Chacon Quiros Juan Jose | Common Shares | Grant | Acquire A | No | No | 0 | 13,519 | 0.00 | 225,735 |
6 Mar 24 | Chacon Quiros Juan Jose | Stock Option Common Shares | Grant | Acquire A | No | No | 49.25 | 19,236 | 947.37 k | 19,236 |
7 Jan 24 | Schutter Edward J | Common Shares | Grant | Acquire A | No | No | 26.91 | 342 | 9.20 k | 304,952 |
7 Jan 24 | Bryan Slotkin | Common Shares | Grant | Acquire A | No | No | 26.91 | 296 | 7.97 k | 21,424 |
News
TD Cowen Maintains Outperform on Establishment Labs Hldgs, Raises Price Target to $60
12 Mar 24
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
29 Feb 24
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
29 Feb 24
JP Morgan Maintains Overweight on Establishment Labs Hldgs, Raises Price Target to $53
29 Feb 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
28 Feb 24
Press releases
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
28 Feb 24
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
23 Feb 24
Establishment Labs Announces Amended Credit Facility with Oaktree
22 Feb 24
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
14 Feb 24
Establishment Labs Announces Commercial Launch of Motiva Implants in China
22 Jan 24